These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23819905)

  • 1. Interrogating differences in expression of targeted gene sets to predict breast cancer outcome.
    Andres SA; Brock GN; Wittliff JL
    BMC Cancer; 2013 Jul; 13():326. PubMed ID: 23819905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-expression of genes with estrogen receptor-α and progesterone receptor in human breast carcinoma tissue.
    Andres SA; Wittliff JL
    Horm Mol Biol Clin Investig; 2012 Dec; 12(1):377-90. PubMed ID: 25436697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel 18-Marker Panel Predicting Clinical Outcome in Breast Cancer.
    Biermann J; Nemes S; Parris TZ; Engqvist H; Rönnerman EW; Forssell-Aronsson E; Steineck G; Karlsson P; Helou K
    Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1619-1628. PubMed ID: 28877888
    [No Abstract]   [Full Text] [Related]  

  • 4. High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.
    Shubbar E; Helou K; Kovács A; Nemes S; Hajizadeh S; Enerbäck C; Einbeigi Z
    BMC Cancer; 2013 Feb; 13():47. PubMed ID: 23374458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.
    Karlsson E; Delle U; Danielsson A; Olsson B; Abel F; Karlsson P; Helou K
    BMC Cancer; 2008 Sep; 8():254. PubMed ID: 18778486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Risk Stratification for Breast Cancer Samples Based on the Expression Ratio of the Estrogen and Progesterone Receptor.
    Bendrat K; Fritz P; Müller S; Brockmöller S; Debus A; Friedrichs K; Lindner C; Brinkmann F; Heidemann E; Niendorf A
    Anticancer Res; 2016 Aug; 36(8):3855-63. PubMed ID: 27466487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression of PMP22 is an independent prognostic factor for disease-free and overall survival in breast cancer patients.
    Tong D; Heinze G; Pils D; Wolf A; Singer CF; Concin N; Hofstetter G; Schiebel I; Rudas M; Zeillinger R
    BMC Cancer; 2010 Dec; 10():682. PubMed ID: 21159173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
    Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
    Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated gene expression profile predicts prognosis of breast cancer patients.
    Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
    Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copy number profiling of Oncotype DX genes reveals association with survival of breast cancer patients.
    Ahmed W; Malik MFA; Saeed M; Haq F
    Mol Biol Rep; 2018 Dec; 45(6):2185-2192. PubMed ID: 30225582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
    Wu JR; Zhao Y; Zhou XP; Qin X
    Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of triple negative phenotype on breast cancer prognosis.
    Kaplan HG; Malmgren JA
    Breast J; 2008; 14(5):456-63. PubMed ID: 18657139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
    Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
    Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide screen identifies a novel prognostic signature for breast cancer survival.
    Mao XY; Lee MJ; Zhu J; Zhu C; Law SM; Snijders AM
    Oncotarget; 2017 Feb; 8(8):14003-14016. PubMed ID: 28122328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling revealed MCM3 to be a better marker than Ki67 in prognosis of invasive ductal breast carcinoma patients.
    Zhao Y; Wang Y; Zhu F; Zhang J; Ma X; Zhang D
    Clin Exp Med; 2020 May; 20(2):249-259. PubMed ID: 31980982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic markers determine both the risk and the timing of recurrence in breast cancer.
    Esserman LJ; Moore DH; Tsing PJ; Chu PW; Yau C; Ozanne E; Chung RE; Tandon VJ; Park JW; Baehner FL; Kreps S; Tutt AN; Gillett CE; Benz CC
    Breast Cancer Res Treat; 2011 Sep; 129(2):607-16. PubMed ID: 21597921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes linked to expression of gene subsets for protein hormones and their cognate receptors from LCM-procured breast carcinoma cells.
    Daniels MW; Brock GN; Wittliff JL
    Breast Cancer Res Treat; 2017 Jan; 161(2):245-258. PubMed ID: 27858316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EarlyR: A Robust Gene Expression Signature for Predicting Outcomes of Estrogen Receptor-Positive Breast Cancer.
    Buechler SA; Gökmen-Polar Y; Badve SS
    Clin Breast Cancer; 2019 Feb; 19(1):17-26.e8. PubMed ID: 30097312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in patients with early-stage breast cancer who underwent a 21-gene expression assay.
    Barcenas CH; Raghavendra A; Sinha AK; Syed MP; Hsu L; Patangan MG; Chavez-MacGregor M; Shen Y; Hortobagyi GH; Valero V; Giordano SH; Ueno NT; Tripathy D
    Cancer; 2017 Jul; 123(13):2422-2431. PubMed ID: 28199747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
    Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
    BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.